18 hrs ago | Archives Internal Medicine
Treatment of Polymyalgia Rheumatica: A Systematic Review
Background Polymyalgia rheumatica treatment is based on low-dose glucocorticoids.
Broken arm blamed on transit bus
An Edmonton senior is suing the City of Edmonton and an Edmonton Transit bus driver for $140,000, alleging she was badly hurt when she tripped on a hydraulic lift used to help the elderly and disabled in boarding.
I was on methotrexate for two years, first the pills and then injectable, but in the end, had to change another medication.
If it's darker and more dried, it might be from further up the digestive system and needs to be checked out further.
New Simponi Data Show Inhibition of Joint Damage in Patients With...
Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis and active psoriatic arthritis .
Favorable Outcome of Juvenile Dermatomyositis Treated without Systemic Corticosteroids.
STUDY DESIGN: A retrospective study of 38 patients with JDM treated at a tertiary care children's hospital identified 8 patients who had never received corticosteroids.
ORENCIA (abatacept) Demonstrated Sustained Clinical Response in a...
Oct 19, 2009 - Bristol-Myers Squibb Company today announced two-year results of a study that supports use of ORENCIA for methotrexate-naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.
Tocilizumab Shows Sustained Efficacy In Rheumatoid Arthritis
Investigators are reporting that tolicizumab is an effective, long-term treatment option in multiple subgroups of rheumatoid arthritis patients.
Study: No Benefit to Costly Arthritis Drugs
For many people with rheumatoid arthritis , the traditional, and much cheaper, disease-modifying antirheumatic drugs appear to work just as well as newer TNF blockers that target the underlying disease process, a large study shows.
Roche Drug Helps Halt Rheumatoid Arthritis Progress
Genentech, Inc., a wholly-owned member of the Roche Group, today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRAA , in combination with methotrexate, had no progression of joint damage, compared with people who received methotrexate alone ...
Phase III Study Showed Two Years Of ACTEMRA(R) (tocilizumab)...
Phase III Study Showed Two Years Of ACTEMRA Inhibited Progression Of Joint Damage And Improved Disease Remission Main Category: Arthritis / Rheumatology Also Included In: Clinical Trials / Drug Trials Article Date: 20 Oct 2009 Genentech, Inc., a wholly-owned member of the Roche Group , announced two-year results from a Phase III study, which ...
Bristol-Myers Squibb says new findings support further development of ...
Bristol-Myers Squibb says new findings support further development of subcutaneous administration of ORENCIA in RA patients Published in M2Europharma on Tuesday, 20 October 2009 at 22:25 GMT 20 October 2009 - US-headquartered Bristol-Myers Squibb Company said today that new clinical data support continued development of a subcutaneous ...
New SIMPONI(TM) Data Show Long-Term Efficacy In Treatment Of Rheumatoid Arthritis
Main Category: Arthritis / Rheumatology Also Included In: Clinical Trials / Drug Trials ; Conferences ; Pharma Industry / Biotech Industry Article Date: 20 Oct 2009 - 1:00 PDT New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis receiving SIMPONI every four weeks achieved sustained ...
Pharmacist not to blame for death, says coroner
A coroner has told a pharmacist who filled an incorrect prescription that led to the death of an 89-year-old woman that he is not to blame for what happened.
FDA Does Not Approve Earlier Use of Rituxan for Rheumatoid Arthritis
Rituxan is approved by the FDA to treat moderate-to-severe rheumatoid arthritis in patients who have had an inadequate response to methotrexate and one or more TNF blockers .
Phase III Study Showed Two Years of ACTEMRA (tocilizumab) Inhibited...
Genentech, Inc., a wholly-owned member of the Roche Group , today announced two-year results from a Phase III study, which showed that people with rheumatoid arthritis who received either a 4 mg/kg or 8 mg/kg dose of ACTEMRA , in combination with methotrexate, had no progression of joint damage, compared with people who received methotrexate alone ...
Significantly Cheaper Drugs as Effective as Expensive Drugs in Treating Early Rheumatoid Arthritis
In the first and largest researcher-initiated blinded study comparing the effectiveness of a drug treatment for rheumatoid arthritis, researchers found a $1,000 treatment and a $25,000 treatment to have the same effectiveness.
FDA Nixes Wider Use of Rheumatoid Arthritis Drug
The Food and Drug Administration has rejected an application to expand the use of rheumatoid arthritis treatment Rituxan for patients with earlier stages of the disease, biotech drug developers Genentech Inc.
Rheumatoid Arthritis Home > Questions > With RA and a suppressed immune system , how does the flu shot work? Receive a FREE Osteoarthritis of the knee pamphlet.
Lover denies plot to frame married doctor by poisoning her own drinks with abortion drug
Spiked: Bella Prowse claims that her lover Edward Erin poisoned her drinks with a drug to make her miscarry A doctor's mistress who accused her hospital consultant lover of spiking her drink to abort their child could have taken the drugs herself, a court heard yesterday.
Also on Topix